San Francisco, United States
molecule.one is an innovative startup operating at the intersection of AI and Pharmaceutical industries. Founded in 2019 and headquartered in the United States, the company is leveraging artificial intelligence and data-driven approaches to design creative and accurate chemical syntheses.
Aligning with its slogan, "Autoresearch for chemistry", molecule.one offers a unique service that enables ordering of custom molecules with rapid delivery, thereby accelerating the process from novel hits to practical applications. Their service promises delivery within a week and novel hits in just four weeks, showcasing a strong commitment to speed and efficiency.
In its last known funding activity, molecule.one secured a $4.60M Seed Round investment on 01 June 2021. This investment round was led by a diverse group of investors including AME Cloud Ventures, Cherubic Ventures, and Sunfish Partners, among others, underscoring robust investor confidence in the company’s strategic direction and potential impact on the market.
Initial Therapeutics